| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004637 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP), neurodegenerative disease, neuropathy in cerebrovascular disease, head trauma, spinal damage, encephalitis sequela, or cerebral palsy, memory disorder |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003620 Morphine sulfate microgranules, method for preparing same and compositions containing same |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | CA2613874A1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs |
| 01/04/2007 | CA2612460A1 Chloro-substituted guanidines |
| 01/04/2007 | CA2611296A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738763A1 Use of complement inhibitory proteins to treat spinal cord injury |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738753A2 New treatments using phenethylamine derivatives |
| 01/03/2007 | EP1737884A1 Alpha helical mimics, their uses and methods for their production |
| 01/03/2007 | EP1737866A2 Compounds with atypical antipsychotic activity |
| 01/03/2007 | EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/03/2007 | EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/03/2007 | EP1737856A1 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 01/03/2007 | EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
| 01/03/2007 | EP1737851A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/03/2007 | EP1737849A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors |
| 01/03/2007 | EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
| 01/03/2007 | EP1737539A1 Therapeutic combination for treatment of alzheimers disease |
| 01/03/2007 | EP1737456A1 Medicament |
| 01/03/2007 | EP1737455A1 Controlled release pharmaceutical composition of tolperisone for oral administration |
| 01/03/2007 | EP1737445A2 Method of treating down syndrome |
| 01/03/2007 | EP1737440A2 Use of ppar delta agonists for treating demyelinating diseases |
| 01/03/2007 | EP1737438A1 alpha-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS |
| 01/03/2007 | EP1737437A1 Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| 01/03/2007 | EP1572685B1 Substituted benzodioxepins |
| 01/03/2007 | EP1485098B1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo¬1,5-b|pyridazine in nanoparticulate form |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | EP1071440B1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/03/2007 | EP1049470B1 Extended release tiagabine formulations with reduced side-effects |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890242A 吡唑并和咪唑并－嘧啶衍生物 And imidazo pyrazolo - pyrimidine derivatives |
| 01/03/2007 | CN1890236A Novel thiazole derivates |
| 01/03/2007 | CN1890227A Benzoxazine derivatives and uses thereof |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1889996A Combination of flupirtine and tramadol |
| 01/03/2007 | CN1889959A Preventive and/or therapeutic agent for higher brain dysfunction |
| 01/03/2007 | CN1889942A Drug containing (2R)-2-propyloctanoic acid as the active ingredient |
| 01/03/2007 | CN1889941A Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 01/03/2007 | CN1889938A Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality |
| 01/03/2007 | CN1889934A Pharmaceutical preparation containing gabapentin |
| 01/03/2007 | CN1887882A Dextro lipoic amidate and its prepn |
| 01/03/2007 | CN1887872A Tetrahydro isoquinoline derivative and its prepn process and medicine use |
| 01/03/2007 | CN1887337A Drunkenness dispelling kudzuvine flower chewing tablet and its prepn |
| 01/03/2007 | CN1887325A Chinese medicine composition and its suppository and application |
| 01/03/2007 | CN1887324A Chinese composition and its prepn process and quality control method |
| 01/03/2007 | CN1887309A Extraction of effective red sage components for preventing and treating osteoporosis and depression |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/03/2007 | CN1293078C Imidazo fused compounds |
| 01/03/2007 | CN1293077C Process for preparing 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293075C Indole and 2,3-indoline derivative, their preparation and application |
| 01/03/2007 | CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 01/03/2007 | CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/03/2007 | CN1293066C Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| 01/03/2007 | CN1293065C Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 01/03/2007 | CN1293064C Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them |
| 01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292781C Medicine for treating mental disease |
| 01/03/2007 | CN1292776C Medicine for treating facial hemiparalysis disease |
| 01/03/2007 | CN1292754C Application of C21 steroid glycoside in pharmacy |
| 01/03/2007 | CN1292749C Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl] |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/03/2007 | CN1292743C Coated solid hyponotic |
| 01/03/2007 | CN1292742C Opioid formulations having extended controlled release |
| 01/03/2007 | CN1292741C Ginseng and schisandra fruit dripping pill and its preparing method |
| 01/03/2007 | CN1292739C Shenerwuwei dripping pill for benefiting qi and nourishing yin and its preparing method |
| 01/03/2007 | CN1292737C Oral administration dripping pill for nourishing heart to calm mind and its preparing method |
| 01/02/2007 | US7157604 Selective estrogen receptor modulators |
| 01/02/2007 | US7157594 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157483 Imidazole derivatives modulating the sodium channels |
| 01/02/2007 | US7157479 Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
| 01/02/2007 | US7157478 For therapy of Alzheimer's disease |